PLAU and neoplasm: To further investigate uPA specificity of 89Zr-Df-ATN-291, “blocking” experiments were conducted with 1 mg (~40 mg/kg) of unlabeled ATN-291 injected into tumor-bearing mice (n = 3) at 2 h before the administration of 89Zr-Df-ATN-291.